The Rapid Evaluation of COVID-19 Vaccination in Emergency Departments for Underserved Patients Study.
COVID-19
/ prevention & control
COVID-19 Vaccines
Cross-Sectional Studies
Emergency Service, Hospital
Female
Health Services Accessibility
Humans
Male
Surveys and Questionnaires
United States
Vaccination
/ statistics & numerical data
Vaccination Refusal
/ statistics & numerical data
Vulnerable Populations
Journal
Annals of emergency medicine
ISSN: 1097-6760
Titre abrégé: Ann Emerg Med
Pays: United States
ID NLM: 8002646
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
received:
02
04
2021
revised:
09
05
2021
accepted:
24
05
2021
pubmed:
18
7
2021
medline:
5
10
2021
entrez:
17
7
2021
Statut:
ppublish
Résumé
Emergency departments (EDs) often serve vulnerable populations who may lack primary care and have suffered disproportionate COVID-19 pandemic effects. Comparing patients having and lacking a regular source of medical care and other ED patient characteristics, we assessed COVID-19 vaccine hesitancy, reasons for not wanting the vaccine, perceived access to vaccine sites, and willingness to get the vaccine as part of ED care. This was a cross-sectional survey conducted from December 10, 2020, to March 7, 2021, at 15 safety net US EDs. Primary outcomes were COVID-19 vaccine hesitancy, reasons for vaccine hesitancy, and sites (including EDs) for potential COVID-19 vaccine receipt. Of 2,575 patients approached, 2,301 (89.4%) participated. Of the 18.4% of respondents who lacked a regular source of medical care, 65% used the ED as their usual source of health care. The overall rate of vaccine hesitancy was 39%; the range among the 15 sites was 28% to 58%. Respondents who lacked a regular source of medical care were more commonly vaccine hesitant than those who had a regular source of medical care (47% versus 38%, 9% difference, 95% confidence interval 4% to 14%). Other characteristics associated with greater vaccine hesitancy were younger age, female sex, Black race, Latinx ethnicity, and not having received an influenza vaccine in the past 5 years. Of the 61% who would accept a COVID-19 vaccine, 21% stated that they lacked a primary physician or clinic at which to receive it; the vast majority (95%) of these respondents would accept the COVID-19 vaccine as part of their care in the ED. ED patients who lack a regular source of medical care are particularly hesitant regarding COVID-19 vaccination. Most COVID-19 vaccine acceptors would accept it as part of their care in the ED. EDs may play pivotal roles in COVID-19 vaccine messaging and delivery to highly vulnerable populations.
Identifiants
pubmed: 34272104
pii: S0196-0644(21)00436-4
doi: 10.1016/j.annemergmed.2021.05.026
pmc: PMC8165082
pii:
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
502-510Subventions
Organisme : NCATS NIH HHS
ID : TL1 TR001883
Pays : United States
Investigateurs
Graham Nichol
(G)
Blair A Parry
(BA)
Alaina Hunt
(A)
Morgan Kelly
(M)
Breena R Taira
(BR)
Michael Pham
(M)
Joshua Tiao
(J)
Kyra Lasko
(K)
Mayuri Aivale
(M)
Alex Farthing
(A)
Nicole Byl
(N)
Virginia Chan
(V)
Nancy Anaya
(N)
Angela H Wong
(AH)
Bhanu Chadalawada
(B)
Anna Tupetz
(A)
Informations de copyright
Copyright © 2021 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.
Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Ann Emerg Med. 2009 May;53(5):598-602
pubmed: 18838193
Acad Emerg Med. 2000 Apr;7(4):354-8
pubmed: 10805623
J Gen Intern Med. 1994 Aug;9(8):425-9
pubmed: 7965235
Math Biosci. 2020 Jul;325:108364
pubmed: 32360770
Ann Emerg Med. 2005 Jan;45(1):4-12
pubmed: 15635299
Front Immunol. 2020 Jul 21;11:1817
pubmed: 32793245
J Community Health. 2020 Dec;45(6):1236-1241
pubmed: 32607750
JAMA. 2021 Mar 2;325(9):883-885
pubmed: 33480971
JAMA. 2020 Jun 23;323(24):2466-2467
pubmed: 32391864
Health Aff (Millwood). 2020 Aug;39(8):1419-1425
pubmed: 32543923
Ann Intern Med. 2020 Dec 15;173(12):964-973
pubmed: 32886525
MMWR Morb Mortal Wkly Rep. 2020 Aug 21;69(33):1122-1126
pubmed: 32817602
Ann Emerg Med. 1993 Nov;22(11):1729-32
pubmed: 8214864
JAMA Netw Open. 2020 Dec 1;3(12):e2033324
pubmed: 33337490
Emerg Med Clin North Am. 2008 May;26(2):549-70, xi
pubmed: 18406987
Vaccine. 2020 Sep 29;38(42):6500-6507
pubmed: 32863069
Acad Emerg Med. 2017 Jan;24(1):63-74
pubmed: 27520382
Am J Emerg Med. 2020 Aug;38(8):1576-1581
pubmed: 31519380
JAMA. 2021 Feb 9;325(6):532-533
pubmed: 33372955
Arch Pediatr Adolesc Med. 2000 Apr;154(4):361-5
pubmed: 10768673
Clin Infect Dis. 2020 Jul 28;71(15):703-705
pubmed: 32282038
Health Aff (Millwood). 2013 Dec;32(12):2069-74
pubmed: 24301388
Health Aff (Millwood). 2021 Jan;40(1):42-52
pubmed: 33211536
JAMA. 2020 Dec 29;:
pubmed: 33372943
J Urban Health. 2016 Jun;93(3):456-67
pubmed: 27193595
Ann Emerg Med. 1998 Nov;32(5):537-43
pubmed: 9795315
Ann Emerg Med. 2019 Nov;74(5S):S28-S30
pubmed: 31655669
JAMA Netw Open. 2021 Jan 4;4(1):e2036462
pubmed: 33512520
JAMA. 2010 Aug 11;304(6):664-70
pubmed: 20699458
Ann Emerg Med. 1999 Mar;33(3):299-303
pubmed: 10036344
MMWR Morb Mortal Wkly Rep. 2021 Mar 05;70(9):329-332
pubmed: 33661860
Heliyon. 2020 Mar 26;6(3):e03474
pubmed: 32258449
Soc Sci Med. 2019 Dec;242:112597
pubmed: 31670216
Eval Rev. 2009 Apr;33(2):138-58
pubmed: 19029360
Nat Rev Immunol. 2020 Oct;20(10):583-584
pubmed: 32908300
Acad Emerg Med. 2013 Feb;20(2):155-61
pubmed: 23406074
BMC Med Res Methodol. 2014 Mar 25;14:42
pubmed: 24669751
Acad Emerg Med. 2002 Nov;9(11):1140-5
pubmed: 12414462
Ann Intern Med. 2020 Aug 4;173(3):233-234
pubmed: 32343767